{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T00:18:19Z","timestamp":1783124299064,"version":"3.54.6"},"reference-count":85,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Veterans Administration Mental Illness, Research, Education and Clinical Center"},{"name":"Research in Addiction Medicine Scholars Program","award":["R25DA033211"],"award-info":[{"award-number":["R25DA033211"]}]},{"name":"National Institute On Drug Abuse of the National Institutes of Health","award":["R01DA042059"],"award-info":[{"award-number":["R01DA042059"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Clinics of North America"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.mcna.2018.02.005","type":"journal-article","created":{"date-parts":[[2018,6,19]],"date-time":"2018-06-19T11:32:37Z","timestamp":1529407957000},"page":"621-634","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Preventing Opioid Overdose in the Clinic and Hospital"],"prefix":"10.1016","volume":"102","author":[{"given":"Stephanie Lee","family":"Peglow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid A.","family":"Binswanger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.mcna.2018.02.005_bib1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12954-017-0135-4","article-title":"The North American opioid epidemic: current challenges and a call for treatment as prevention","volume":"14","author":"Vashishtha","year":"2017","journal-title":"Harm Reduct J"},{"issue":"14","key":"10.1016\/j.mcna.2018.02.005_bib2","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1001\/jama.2015.11859","article-title":"Nonmedical prescription opioid use and use disorders among adults aged 18 through 64 years in the United States, 2003-2013","volume":"314","author":"Han","year":"2015","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.mcna.2018.02.005_bib3","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2105\/AJPH.2007.131714","article-title":"The promotion and marketing of oxycontin: commercial triumph, public health tragedy","volume":"99","author":"Van Zee","year":"2009","journal-title":"Am J Public Health"},{"issue":"8","key":"10.1016\/j.mcna.2018.02.005_bib4","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1377\/hlthaff.2012.0846","article-title":"A\u00a0call for evidence-based medical treatment of opioid dependence in the United States and Canada","volume":"32","author":"Nosyk","year":"2013","journal-title":"Health Aff (Millwood)"},{"key":"10.1016\/j.mcna.2018.02.005_bib5","unstructured":"Administration SAaMHS. SAMSHA opioid overdose prevention toolkit: opioid overdose prevention TOOLKIT: information for prescribers. 2013. Available at: https:\/\/store.samhsa.gov\/product\/SAMHSA-Opioid-Overdose-Prevention-Toolkit\/SMA16-4742. Accessed August 1, 2017."},{"issue":"7","key":"10.1016\/j.mcna.2018.02.005_bib6","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1001\/jama.2013.272","article-title":"Pharmaceutical overdose deaths, United States, 2010","volume":"309","author":"Jones","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.mcna.2018.02.005_bib7","unstructured":"The Opioid Therapy for Chronic Pain Work Group. VA\/DoD Clinical Practice Guidelines for Opioid Therapy for Chronic Pain. Version 3.0- February 2017. Available at: https:\/\/www.healthquality.va.gov\/guidelines\/Pain\/cot\/VADoDOTCPG022717.pdf. Accessed August 1, 2017."},{"issue":"18","key":"10.1016\/j.mcna.2018.02.005_bib8","doi-asserted-by":"crossref","first-page":"E659","DOI":"10.1503\/cmaj.170363","article-title":"Guideline for opioid therapy and chronic noncancer pain","volume":"189","author":"Busse","year":"2017","journal-title":"CMAJ"},{"issue":"15","key":"10.1016\/j.mcna.2018.02.005_bib9","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/jama.2016.1464","article-title":"CDC guideline for prescribing opioids for chronic pain: United States, 2016","volume":"315","author":"Dowell","year":"2016","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.mcna.2018.02.005_bib10","doi-asserted-by":"crossref","first-page":"276","DOI":"10.7326\/M14-2559","article-title":"The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health Pathways to Prevention Workshop","volume":"162","author":"Chou","year":"2015","journal-title":"Ann Intern Med"},{"issue":"12","key":"10.1016\/j.mcna.2018.02.005_bib11","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1007\/s11606-015-3394-3","article-title":"Overdose education and naloxone for patients prescribed opioids in primary care: a qualitative study of primary care staff","volume":"30","author":"Binswanger","year":"2015","journal-title":"J\u00a0Gen Intern Med"},{"issue":"2","key":"10.1016\/j.mcna.2018.02.005_bib12","first-page":"113","article-title":"Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain","volume":"10","author":"Chou","year":"2009","journal-title":"J\u00a0Pain"},{"issue":"8","key":"10.1016\/j.mcna.2018.02.005_bib13","doi-asserted-by":"crossref","first-page":"e0134550","DOI":"10.1371\/journal.pone.0134550","article-title":"Sex differences in dose escalation and overdose death during chronic opioid therapy: a population-based cohort study","volume":"10","author":"Kaplovitch","year":"2015","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.mcna.2018.02.005_bib14","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s11606-015-3539-4","article-title":"Opioid prescribing at hospital discharge contributes to chronic opioid use","volume":"31","author":"Calcaterra","year":"2016","journal-title":"J\u00a0Gen Intern Med"},{"key":"10.1016\/j.mcna.2018.02.005_bib15","series-title":"Opioid abuse in the US and HHS actions to address opioid-drug related overdoses and death","year":"2015"},{"issue":"1\u20132","key":"10.1016\/j.mcna.2018.02.005_bib16","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.pain.2004.07.026","article-title":"Validation of a screener and opioid assessment measure for patients with chronic pain","volume":"112","author":"Butler","year":"2004","journal-title":"Pain"},{"issue":"8","key":"10.1016\/j.mcna.2018.02.005_bib17","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1007\/s11606-015-3199-4","article-title":"Drug overdose in a retrospective cohort with non-cancer pain treated with opioids, antidepressants, and\/or sedative-hypnotics: interactions with mental health disorders","volume":"30","author":"Turner","year":"2015","journal-title":"J\u00a0Gen Intern Med"},{"issue":"2","key":"10.1016\/j.mcna.2018.02.005_bib18","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1080\/08897077.2015.1010032","article-title":"A\u00a0review of opioid overdose prevention and naloxone prescribing: implications for translating community programming into clinical practice","volume":"36","author":"Mueller","year":"2015","journal-title":"Subst Abus"},{"issue":"13","key":"10.1016\/j.mcna.2018.02.005_bib19","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1001\/jama.2011.370","article-title":"Association between opioid prescribing patterns and opioid overdose-related deaths","volume":"305","author":"Bohnert","year":"2011","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.mcna.2018.02.005_bib20","doi-asserted-by":"crossref","first-page":"491","DOI":"10.4088\/JCP.09m05567blu","article-title":"Mental illness and psychotropic drug use among prescription drug overdose deaths: a medical examiner chart review","volume":"71","author":"Toblin","year":"2010","journal-title":"J\u00a0Clin Psychiatry"},{"issue":"2","key":"10.1016\/j.mcna.2018.02.005_bib21","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3109\/15360288.2015.1037530","article-title":"Opioid abuse in the United States and Department of Health and Human Services actions to address opioid-drug-related overdoses and deaths","volume":"29","year":"2015","journal-title":"J\u00a0Pain Palliat Care Pharmacother"},{"issue":"4","key":"10.1016\/j.mcna.2018.02.005_bib22","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1001\/jamainternmed.2014.8071","article-title":"Prescription opioid duration of action and the risk of unintentional overdose among patients receiving opioid therapy","volume":"175","author":"Miller","year":"2015","journal-title":"JAMA Intern Med"},{"issue":"7","key":"10.1016\/j.mcna.2018.02.005_bib23","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1197\/j.aem.2007.04.005","article-title":"Identifying injection drug users at risk of nonfatal overdose","volume":"14","author":"Coffin","year":"2007","journal-title":"Acad Emerg Med"},{"issue":"2","key":"10.1016\/j.mcna.2018.02.005_bib24","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1056\/NEJMsa064115","article-title":"Release from prison: a high risk of death for former inmates","volume":"356","author":"Binswanger","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.mcna.2018.02.005_bib25","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/AJP.0000000000000021","article-title":"The role of opioid prescription in incident opioid abuse and dependence among individuals with chronic noncancer pain: the role of opioid prescription","volume":"30","author":"Edlund","year":"2014","journal-title":"Clin J Pain"},{"issue":"9","key":"10.1016\/j.mcna.2018.02.005_bib26","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1001\/jamainternmed.2017.2468","article-title":"Improving adherence to long-term opioid therapy guidelines to reduce opioid misuse in primary care: a cluster-randomized clinical trial","volume":"177","author":"Liebschutz","year":"2017","journal-title":"JAMA Intern Med"},{"issue":"2","key":"10.1016\/j.mcna.2018.02.005_bib27","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1080\/08897077.2014.991058","article-title":"Pharmaceutical opioids in the home and youth: implications for adult medical practice","volume":"36","author":"Binswanger","year":"2015","journal-title":"Subst Abus"},{"issue":"4","key":"10.1016\/j.mcna.2018.02.005_bib28","doi-asserted-by":"crossref","first-page":"665","DOI":"10.2105\/AJPH.2012.301209","article-title":"Longitudinal effects of universal preventive intervention on prescription drug misuse: three randomized controlled trials with late adolescents and young adults","volume":"103","author":"Spoth","year":"2013","journal-title":"Am J Public Health"},{"issue":"5","key":"10.1016\/j.mcna.2018.02.005_bib29","doi-asserted-by":"crossref","first-page":"e1330","DOI":"10.1542\/peds.2011-1754","article-title":"Substance use screening, brief intervention, and referral to treatment for pediatricians","volume":"128","author":"Levy","year":"2011","journal-title":"Pediatrics"},{"issue":"6","key":"10.1016\/j.mcna.2018.02.005_bib30","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1001\/archpedi.156.6.607","article-title":"Validity of the CRAFFT substance abuse screening test among adolescent clinic patients","volume":"156","author":"Knight","year":"2002","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"11","key":"10.1016\/j.mcna.2018.02.005_bib31","doi-asserted-by":"crossref","first-page":"712","DOI":"10.7326\/0003-4819-152-11-201006010-00004","article-title":"Systematic review: treatment agreements and urine drug testing to reduce opioid misuse in patients with chronic pain","volume":"152","author":"Starrels","year":"2010","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.mcna.2018.02.005_bib32","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/ADM.0000000000000323","article-title":"Appropriate use of drug testing in clinical addiction medicine","volume":"11","author":"Jarvis","year":"2017","journal-title":"J addict med."},{"key":"10.1016\/j.mcna.2018.02.005_bib33","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.drugalcdep.2017.05.023","article-title":"Impact of New York prescription drug monitoring program, I-STOP, on statewide overdose morbidity","volume":"178","author":"Brown","year":"2017","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.mcna.2018.02.005_bib34","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.drugalcdep.2014.10.001","article-title":"What we know, and don't know, about the impact of state policy and systems-level interventions on prescription drug overdose","volume":"145","author":"Haegerich","year":"2014","journal-title":"Drug Alcohol Depend"},{"issue":"5","key":"10.1016\/j.mcna.2018.02.005_bib35","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/j.1526-4637.2011.01062.x","article-title":"Prescription drug monitoring programs and death rates from drug overdose","volume":"12","author":"Paulozzi","year":"2011","journal-title":"Pain Med"},{"issue":"3","key":"10.1016\/j.mcna.2018.02.005_bib36","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1377\/hlthaff.2012.0945","article-title":"Measures such as interstate cooperation would improve the efficacy of programs to track controlled drug prescriptions","volume":"32","author":"Deyo","year":"2013","journal-title":"Health Aff (Millwood)"},{"issue":"4","key":"10.1016\/j.mcna.2018.02.005_bib37","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/j.1526-4637.2007.00370.x","article-title":"What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse\/addiction and\/or aberrant drug-related behaviors? A structured evidence-based review","volume":"9","author":"Fishbain","year":"2008","journal-title":"Pain Med"},{"issue":"3","key":"10.1016\/j.mcna.2018.02.005_bib38","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s11606-016-3895-8","article-title":"Attitudes toward naloxone prescribing in clinical settings: a qualitative study of patients prescribed high dose opioids for chronic non-cancer pain","volume":"32","author":"Mueller","year":"2017","journal-title":"J\u00a0Gen Intern Med"},{"issue":"2","key":"10.1016\/j.mcna.2018.02.005_bib39","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.pain.2010.11.006","article-title":"Identifying prescription opioid use disorder in primary care: diagnostic characteristics of the current opioid misuse measure (COMM)","volume":"152","author":"Meltzer","year":"2011","journal-title":"Pain"},{"issue":"5","key":"10.1016\/j.mcna.2018.02.005_bib40","doi-asserted-by":"crossref","first-page":"257","DOI":"10.5055\/jom.2005.0055","article-title":"Monitoring outcomes during long-term opioid therapy for noncancer pain: results with the pain assessment and documentation tool","volume":"1","author":"Passik","year":"2005","journal-title":"J\u00a0Opioid Manag"},{"issue":"12","key":"10.1016\/j.mcna.2018.02.005_bib41","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1093\/pm\/pnx243","article-title":"Group visits for overdose education and naloxone distribution in primary care: a pilot quality improvement initiative","volume":"18","author":"Spelman","year":"2017","journal-title":"Pain Med"},{"issue":"6","key":"10.1016\/j.mcna.2018.02.005_bib42","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s11606-009-0981-1","article-title":"Development and initial validation of the PEG, a three-item scale assessing pain intensity and interference","volume":"24","author":"Krebs","year":"2009","journal-title":"J\u00a0Gen Intern Med"},{"issue":"2","key":"10.1016\/j.mcna.2018.02.005_bib43","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1056\/NEJMra1508490","article-title":"Relationship between nonmedical prescription-opioid use and heroin use","volume":"374","author":"Compton","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.mcna.2018.02.005_bib44","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1093\/pm\/pnw078","article-title":"Patients\u2019 perspectives on tapering of chronic opioid therapy: a qualitative study","volume":"17","author":"Frank","year":"2016","journal-title":"Pain Med"},{"issue":"3","key":"10.1016\/j.mcna.2018.02.005_bib45","doi-asserted-by":"crossref","first-page":"181","DOI":"10.7326\/M17-0598","article-title":"Patient outcomes in dose reduction or discontinuation of long-term opioid therapy: a systematic review","volume":"167","author":"Frank","year":"2017","journal-title":"Ann Intern Med"},{"issue":"23","key":"10.1016\/j.mcna.2018.02.005_bib46","first-page":"631","article-title":"Opioid overdose prevention programs providing naloxone to laypersons\u2014United States, 2014","volume":"64","author":"Wheeler","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.mcna.2018.02.005_bib47","doi-asserted-by":"crossref","first-page":"f174","DOI":"10.1136\/bmj.f174","article-title":"Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis","volume":"346","author":"Walley","year":"2013","journal-title":"BMJ"},{"issue":"10","key":"10.1016\/j.mcna.2018.02.005_bib48","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1111\/j.1360-0443.2008.02314.x","article-title":"Overdose training and take-home naloxone for opiate users: prospective cohort study of impact on knowledge and attitudes and subsequent management of overdoses","volume":"103","author":"Strang","year":"2008","journal-title":"Addiction"},{"issue":"6","key":"10.1016\/j.mcna.2018.02.005_bib49","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1111\/j.1360-0443.2008.02182.x","article-title":"Distinguishing signs of opioid overdose and indication for naloxone: an evaluation of six overdose training and naloxone distribution programs in the United States","volume":"103","author":"Green","year":"2008","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.mcna.2018.02.005_bib50","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.drugpo.2008.02.004","article-title":"\u201cThe life they save may be mine\u201d: diffusion of overdose prevention information from a city sponsored programme","volume":"20","author":"Sherman","year":"2009","journal-title":"Int J Drug Policy"},{"issue":"3","key":"10.1016\/j.mcna.2018.02.005_bib51","doi-asserted-by":"crossref","first-page":"381","DOI":"10.5811\/westjem.2015.2.24909","article-title":"Opioid education and nasal naloxone rescue kits in the emergency department","volume":"16","author":"Dwyer","year":"2015","journal-title":"West J Emerg Med"},{"issue":"4","key":"10.1016\/j.mcna.2018.02.005_bib52","doi-asserted-by":"crossref","first-page":"245","DOI":"10.7326\/M15-2771","article-title":"Nonrandomized intervention study of naloxone coprescription for primary care patients receiving long-term opioid therapy for pain","volume":"165","author":"Coffin","year":"2016","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.mcna.2018.02.005_bib53","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1080\/08897077.2016.1238431","article-title":"Co-prescribing naloxone does not increase liability risk","volume":"37","author":"Davis","year":"2016","journal-title":"Subst Abus"},{"key":"10.1016\/j.mcna.2018.02.005_bib54","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.drugalcdep.2016.03.018","article-title":"A\u00a0pilot randomized clinical trial of an intervention to reduce overdose risk behaviors among emergency department patients at risk for prescription opioid overdose","volume":"163","author":"Bohnert","year":"2016","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"10.1016\/j.mcna.2018.02.005_bib55","first-page":"1","article-title":"Opioid overdose prevention and naloxone rescue kits: what we know and what we don\u2019t know","volume":"12","author":"Kerensky","year":"2017","journal-title":"Addict Sci Clin Pract"},{"key":"10.1016\/j.mcna.2018.02.005_bib56","series-title":"SAMHSA opioid overdose prevention toolkit","year":"2013"},{"issue":"4","key":"10.1016\/j.mcna.2018.02.005_bib57","doi-asserted-by":"crossref","first-page":"605","DOI":"10.15288\/jsad.2013.74.605","article-title":"Buprenorphine\/naloxone and methadone maintenance treatment outcomes for opioid analgesic, heroin, and combined users: findings from Starting Treatment With Agonist Replacement Therapies (START)","volume":"74","author":"Potter","year":"2013","journal-title":"J\u00a0Stud Alcohol Drugs"},{"issue":"22","key":"10.1016\/j.mcna.2018.02.005_bib58","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1056\/NEJMp1402780","article-title":"Medication-assisted therapies: tackling the opioid-overdose epidemic","volume":"370","author":"Volkow","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.mcna.2018.02.005_bib59","first-page":"1269","article-title":"Canadian guideline for safe and effective use of opioids for chronic noncancer pain: clinical summary for family physicians. Part 2: special populations","volume":"57","author":"Kahan","year":"2011","journal-title":"Can Fam Physician"},{"issue":"2","key":"10.1016\/j.mcna.2018.02.005_bib60","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1081\/ADA-120002972","article-title":"Treatment of heroin dependence with buprenorphine in primary care","volume":"28","author":"Fiellin","year":"2002","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"4","key":"10.1016\/j.mcna.2018.02.005_bib61","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.jadohealth.2012.08.007","article-title":"Leftover prescription opioids and nonmedical use among high school seniors: a multi-cohort national study","volume":"52","author":"McCabe","year":"2013","journal-title":"J\u00a0Adolesc Health"},{"issue":"5","key":"10.1016\/j.mcna.2018.02.005_bib62","doi-asserted-by":"crossref","first-page":"376","DOI":"10.7326\/L16-0168","article-title":"Opioid prescribing after nonfatal overdose and association with repeated overdose","volume":"165","author":"Larochelle","year":"2016","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.mcna.2018.02.005_bib63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/AJP.0b013e3181b99f35","article-title":"Trends in use of opioids for chronic noncancer pain among individuals with mental health and substance use disorders: the TROUP study","volume":"26","author":"Edlund","year":"2010","journal-title":"Clin J Pain"},{"issue":"2","key":"10.1016\/j.mcna.2018.02.005_bib64","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/pme.12594","article-title":"Benzodiazepine use among chronic pain patients prescribed opioids: associations with pain, physical and mental health, and health service utilization","volume":"16","author":"Nielsen","year":"2015","journal-title":"Pain Med"},{"issue":"9","key":"10.1016\/j.mcna.2018.02.005_bib65","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1001\/jama.2012.234","article-title":"Association of mental health disorders with prescription opioids and high-risk opioid use in US veterans of Iraq and Afghanistan","volume":"307","author":"Seal","year":"2012","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.mcna.2018.02.005_bib66","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.pain.2005.08.006","article-title":"The association between negative affect and opioid analgesia in patients with discogenic low back pain","volume":"117","author":"Wasan","year":"2005","journal-title":"Pain"},{"issue":"3","key":"10.1016\/j.mcna.2018.02.005_bib67","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.pain.2007.02.014","article-title":"Risk factors for clinically recognized opioid abuse and dependence among veterans using opioids for chronic non-cancer pain","volume":"129","author":"Edlund","year":"2007","journal-title":"Pain"},{"issue":"7","key":"10.1016\/j.mcna.2018.02.005_bib68","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s11606-015-3220-y","article-title":"Association of care practices with suicide attempts in US veterans prescribed opioid medications for chronic pain management","volume":"30","author":"Im","year":"2015","journal-title":"J\u00a0Gen Intern Med"},{"issue":"3","key":"10.1016\/j.mcna.2018.02.005_bib69","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/sltb.12014","article-title":"The impact of exercise on suicide risk: examining pathways through depression, PTSD, and sleep in an inpatient sample of veterans","volume":"43","author":"Davidson","year":"2013","journal-title":"Suicide Life Threat Behav"},{"issue":"4","key":"10.1016\/j.mcna.2018.02.005_bib70","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/PEC.0000000000000102","article-title":"Trends in prescription opioid use in pediatric emergency department patients","volume":"30","author":"Mazer-Amirshahi","year":"2014","journal-title":"Pediatr Emerg Care"},{"issue":"5","key":"10.1016\/j.mcna.2018.02.005_bib71","doi-asserted-by":"crossref","first-page":"e1169","DOI":"10.1542\/peds.2015-1364","article-title":"Prescription opioids in adolescence and future opioid misuse","volume":"136","author":"Miech","year":"2015","journal-title":"Pediatrics"},{"issue":"12","key":"10.1016\/j.mcna.2018.02.005_bib72","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1111\/j.1360-0443.2007.02015.x","article-title":"Does early onset of non-medical use of prescription drugs predict subsequent prescription drug abuse and dependence? Results from a national study","volume":"102","author":"McCabe","year":"2007","journal-title":"Addiction"},{"issue":"23","key":"10.1016\/j.mcna.2018.02.005_bib73","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1001\/jama.279.23.1877","article-title":"Management of pain in elderly patients with cancer. SAGE Study Group. Systematic Assessment of Geriatric Drug Use via Epidemiology","volume":"279","author":"Bernabei","year":"1998","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.mcna.2018.02.005_bib74","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ejpain.2004.07.011","article-title":"Opioid use in the elderly","volume":"9","author":"Wilder-Smith","year":"2005","journal-title":"Eur J Pain"},{"issue":"9","key":"10.1016\/j.mcna.2018.02.005_bib75","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s11920-016-0718-x","article-title":"Alcohol and opioid use disorder in older adults: neglected and treatable illnesses","volume":"18","author":"Le Roux","year":"2016","journal-title":"Curr Psychiatry Rep"},{"issue":"4","key":"10.1016\/j.mcna.2018.02.005_bib76","doi-asserted-by":"crossref","first-page":"314.e1-11","DOI":"10.1016\/j.ajog.2010.12.039","article-title":"Maternal treatment with opioid analgesics and risk for birth defects","volume":"204","author":"Broussard","year":"2011","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.mcna.2018.02.005_bib77","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1097\/AOG.0b013e318256496e","article-title":"ACOG committee opinion no. 524: opioid abuse, dependence, and addiction in pregnancy","volume":"119","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.mcna.2018.02.005_bib78","series-title":"Clinical use of extended-release injectable naltrexone in the treatment of opioid use disorder: a brief guide","author":"Administration SAaMHS","year":"2015"},{"key":"10.1016\/j.mcna.2018.02.005_bib79","series-title":"Patient education Fact Sheet: Important information about opioid use disorder and pregnancy","year":"2016"},{"issue":"2","key":"10.1016\/j.mcna.2018.02.005_bib80","first-page":"126","article-title":"Nonopioid substance use disorders and opioid dose predict therapeutic opioid addiction","volume":"16","author":"Huffman","year":"2015","journal-title":"J\u00a0Pain"},{"issue":"2","key":"10.1016\/j.mcna.2018.02.005_bib81","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/HRP.0000000000000052","article-title":"Long-term course of opioid addiction","volume":"23","author":"Hser","year":"2015","journal-title":"Harv Rev Psychiatry"},{"issue":"13","key":"10.1016\/j.mcna.2018.02.005_bib82","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1001\/archinternmed.2010.140","article-title":"A\u00a0single-question screening test for drug use in primary care","volume":"170","author":"Smith","year":"2010","journal-title":"Arch Intern Med"},{"issue":"2","key":"10.1016\/j.mcna.2018.02.005_bib83","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jsat.2006.08.002","article-title":"A\u00a0comprehensive review of the psychometric properties of the drug abuse screening test","volume":"32","author":"Yudko","year":"2007","journal-title":"J\u00a0Subst Abuse Treat"},{"issue":"2","key":"10.1016\/j.mcna.2018.02.005_bib84","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1530-0277.2006.00295.x","article-title":"The alcohol use disorders identification test: an update of research findings","volume":"31","author":"Reinert","year":"2007","journal-title":"Alcohol Clin Exp Res"},{"issue":"8","key":"10.1016\/j.mcna.2018.02.005_bib85","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.2105\/AJPH.2015.302664","article-title":"National and state treatment need and capacity for opioid agonist medication-assisted treatment","volume":"105","author":"Jones","year":"2015","journal-title":"Am J Public Health"}],"container-title":["Medical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712518300099?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712518300099?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T23:14:49Z","timestamp":1661469289000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025712518300099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":85,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S0025712518300099"],"URL":"https:\/\/doi.org\/10.1016\/j.mcna.2018.02.005","relation":{},"ISSN":["0025-7125"],"issn-type":[{"value":"0025-7125","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preventing Opioid Overdose in the Clinic and Hospital","name":"articletitle","label":"Article Title"},{"value":"Medical Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcna.2018.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}